NLRX1 and colorectal carcinoma: To test this hypothesis, NLRX1−/− and WT mice received five weekly intraperitoneal injections with the carcinogen AOM, which induces colorectal cancer (CRC), and animals were sacrificed at week 26 after the first AOM injection.